Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bempedoic Acid Add-on to Ezetimibe in Statin-Intolerant Patients (CLEAR Tranquility)
NCT03001076Phase 3Completed
- Sponsor
- Esperion Therapeutics
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bempedoic acid in hypercholesterolemia, sponsored by Esperion Therapeutics. Started Nov 2016; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03001076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001076.